The objective of the present study was to investigate if there was a difference in baseline serum concentrations of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) between groups with and without cardiovascular events during a mean follow-up of 6.6 years in a group of initially healthy 58-year-old men. A further aim was to examine if high serum concentrations of ICAM-1 and VCAM-1 were associated with carotid and femoral artery plaque occurrence, separately. Men with cardiovascular events during follow-up had higher median serum ICAM-I and VCAM-I than those without events (P < .05). The median of serum ICAM-I and VCAM-1 in the event group was used as the cutoff level, and in those with ICAM-1 and VCAM-1 above the cutoff value, there was an increased risk of having a plaque in the femoral artery (OR = 2.8, 95% CI = 1.8-4.3; and OR = 1.6, 95% CI = 1.1-2.5, respectively).
BlankenbergS., BarbauxS., TiretL.Adhesion molecules and atherosclerosis.Atherosclerosis.2003; 170: 191–203.
2.
HopeS.A., MeredithI.T.Cellular adhesion molecules and cardiovascular disease. Part II. Their association with conventional and emerging risk factors, acute coronary events and cardiovascular risk prediction.Internal Med J.2003; 33: 450–462.
3.
HopeS.A., MeredithI.T.Cellular adhesion molecules and cardiovascular disease. Part I. Their expression and role in atherogenesis.Internal Med J.2003; 33: 380–386.
4.
HwangS-J, BallantyneC.M., SharrettA.R.Circulating adhesion molecules VCAM-1, ICAM-1 and E-selectin in carotid atherosclerosis and incident coronary heart disease cases. The Atherosclerosis Risk in Communities (ARIC) Study.Circulation.1997; 96: 4219–4225.
TanneD., HaimM., BoykoV.Soluble intercellular adhesion molecule-l and risk of future ischemic stroke. A nested case-control study from the Bezafibrate Infarction Prevention (BIP) Study Cohort.Stroke.2002; 33: 2182–2186.
7.
RidkerP.M., HennekensC.H., Roitman-JohnsonB.Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.Lancet.1998; 352: 88–92.
8.
de LemosJ.A., HennekensC.H., RidkerP.M.Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk.J Am Coll Cardiol.2000; 36: 423–426.
9.
GlagovS., ZainsC., GiddensD.P.Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries.Arch Pathol Lab Med.1988; 112: 1018–1031.
10.
WillekesC., BrandsP.J., WillegersJ.M.Assessment of local differences in intima-media thickness in the human common carotid arteries.J Vasc Res.1999; 36: 222–228.
11.
BrohallG., OdénA., FagerbergB.Carotid artery intima-media thickness in patients with type 2 diabetes mellitus and impaired glucose tolerance: a systematic review.Diabet Med.2006; 23: 609–616.
12.
HultheJ., WikstrandJ., EmanuelssonH.Atherosclerotic changes in the carotid artery bulb as measured by B-mode ultrasound are associated with the extent of coronary atherosclerosis.Stroke.1997; 28: 1189–1194.
13.
HollanderM., BotsM.L., Iglesias del SolA.Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly. The Rotterdam Study.Circulation.2002; 105: 2872–2877.
14.
HeldC., HjelmdahlP., ErikssonS.V.Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris.Eur Heart J.2001; 22: 62–72.
15.
SchmidtC., FagerbergB., HultheJ.Non-stenotic ultrasound assessed femoral artery plaques are predictive for future cardiovascular events in middle-aged men.Atherosclerosis.2005; 181: 125–130.
16.
BokemarkL., WikstrandJ., WedelH.Insulin, insulin properties and intima-media thickness in the carotid artery in 58-year-old clinically healthy men. The atherosclerosis and insulin resistance study (AIR).Diabetic Med.2002; 19: 144–151.
17.
SchmidtC., FagerbergB., WikstrandJ.ApoB/apoA-I ratio is related to femoral artery plaques and is predictive for future cardiovascular events in healthy men.Atherosclerosis.2006; 189: 178–185.
18.
SigurdardottírV., FagerbergB., HultheJ.Circulating oxidized low-density lipoprotein (LDL) is associated with factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR-study).J Int Med.2002; 252: 440–447.
19.
WendelhagI., WiklundO., WikstrandJ.Intima-media thickness after cholesterol lowering in familial hypercholesterolemia. A three year ultrasound study of common carotid and femoral arteries.Atherosclerosis.1995; 117: 225–236.
20.
HultheJ., WikstrandJ., FagerbergB.Relationship between C-reactive protein and intima-media thickness in the carotid and femoral arteries and to antibodies against oxidized low-density lipoprotein in healthy men: the Atherosclerosis and Insulin Resistance (AIR) study.Clin Sci (Land).2001; 100: 371–378.
21.
AgewallS., FagerbergB., BerglundG. for the Risk Factor Intervention Study Group, Sweden. Multiple risk intervention trial in high risk hypertensive men: comparison of ultrasound intima-media thickness and clinical outcome during 6 years of follow-up.J Int Med.2001; 249: 305–314.
22.
BongardV., EliasA., Bal dit SollierC.Soluble intercellular adhesion molecule-1 is associated with carotid and femoral atherosclerosis but not with intima-media thickness in a population-based sample.Atherosclerosis.2002; 164: 297–304.
23.
HultheJ., WikstrandJ., Mattson-HulthénL.Circulating ICAM-1 (intercellular cell-adhesion molecule 1) is associated with early stages of atherosclerosis development and with inflammatory cytokines in healthy 58–year-old men: the Atherosclerosis and Insulin Resistance (AIR) study.Clin Sci (Lond).2002; 103: 123–129.
24.
KrogerK., KuchsrczikA., HircheH.Atherosclerotic lesions are more frequent in femoral arteries than in carotid arteries independent of increasing number of risk factors.Angiology.1999; 50: 649–654.
25.
SonowskiC., PasierskiT., Janeczko-SonowskaE.Femoral rather than carotid artery ultrasound imaging predicts extent and severity of coronary artery disease.Kardiol Pol.2007; 65: 760–766.
26.
FowkesF., HousleyE., CawoodE.Edinburgh artery study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population.Int J Epidemiol.1991; 20: 384–392.
27.
BelcaroG., FischerC., VellerM.Screening asymptomatic subjects with subclinical atherosclerotic lesions with arterial ultrasonic biopsy. The P. A. P. Study.Vasa.1993; 22: 232–240.
28.
JounalaM., ViikariJ.S.A., RönnemaaT.Elevated blood pressure in adolescent boys predicts endothelial dysfunction: the cardiovascular risk in young Finns study.Hypertension.2006; 48: 424–430.
29.
TariverdiH., EvrengulH., KuruO.Cigarette smoking induced oxidative stress may impair endothelial function and coronary blood flow in angiographically normal coronary arteries.Circ J.2006; 70: 593–599.
30.
Rask-MadsenC., KingG.L.Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes.Nat Clin Pract Endocrinol Metab.2007; 3: 46–56.
31.
GlassC.K., WitztumJ.L.Atherosclerosis: the road ahead.Cell.2001; 104: 503–516.
32.
ChiassonJ-L, JosseR.G., GomisR.Acarbose treatment and risk of cardiovascular disease. An update.JAMA.2003; 290: 486–494.
33.
BushT.L., MillerS.R., GoldenA.L.Self-report and medical record report agreement of selected medical conditions in the elderly.Am J Public Health.1989; 79: 1554–1556.
34.
RosamondW.D., SprafkaJ.M., McGovernP.G.Validation of self-reported history of acute myocardial infarction: experience of the Minnesota Heart Survey Registry.Epidemiology.1995; 6: 67–69.
35.
HaapanenN., MiilunpaloS., PasanenM.Agreement between questionnaire data and medical records of chronic diseases in middle-aged and elderly Finnish men and women.Am J Epidemiol.1997; 145: 762–769.
36.
LampeF.C., WalkerM., LennonL.T.Validity of a self-reported history of doctor-diagnosed angina.J Clin Epidemiol.1999; 52: 73–81.
37.
HoldsworthR.J., McCollumP.T., BryceJ.S.Symptoms, stenosis and carotid plaque morphology. Is plaque morphology relevant?Eur J Vasc Endovasc Surg.1995; 9: 80–85.
